Belite Bio, Inc
BLTE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001889109
In the last 90 days, Belite Bio, Inc insiders filed 0 open-market purchases and 4 sales; 80 institutions reported holding it in 13F filings for Q2 2026, worth $1.44B in total; superinvestors Maverick Capital and Duquesne Family Office hold it.
Holders of 5% or more of BLTE
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Belite Bio, Inc, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Lin Bioscience International Ltd. | 13G | 53.70%17.1M shares | New | Jan 21, 20251 filing | Jan 21, 2025 | SEC |
| Darwin Global Management, Ltd. | 13G/A | 8.10%3.03M shares | +1.10 ppfrom 7.00% | Dec 10, 20252 filings | Feb 17, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
5 Schedule 13D and 13G filings on Belite Bio, Inc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| May 14, 20264:00 PM ET | Lin Yu-Hsin | 13G/A | 3.10%1.25M shares | −4.00 ppfrom 7.10%Below 5% | Mar 31, 2026 | SEC |
| Feb 17, 20264:30 PM ET | Darwin Global Management, Ltd.and 2 others | 13G/A | 8.10%3.03M shares | +1.10 ppfrom 7.00% | Dec 31, 2025 | SEC |
| Dec 10, 20254:30 PM ET | Darwin Global Management, Ltd.and 2 others | 13G | 7.00%2.62M shares | New | Dec 3, 2025 | SEC |
| Jan 21, 20256:02 AM ET | Lin Yu-Hsin | 13G | 7.10%2.29M shares | New | Dec 31, 2024 | SEC |
| Jan 21, 20256:01 AM ET | Lin Bioscience International Ltd. | 13G | 53.70%17.1M shares | New | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Belite Bio, Inc shares.
No Form 144 notices for Belite Bio, Inc are on file.